A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non–muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14

Bcg Therapy ◽

Muscle Invasive ◽

Results of a phase I/II single arm clinical trial assessing efficacy, safety and tolerability of the recombinant Bacillus Calmette Guérin VPM1002BC in patients with non-muscle invasive bladder cancer recurrence after BCG induction with or without BCG maintenance therapy – SAKK 06/14

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2020.10.027 ◽

2020 ◽

Vol 38 (12) ◽

pp. 898

Author(s):

Cyrill A Rentsch ◽

George N Thalmann ◽

Ilaria Lucca ◽

Maciej Kwiatkowski ◽

Grégory J Wirth ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Maintenance Therapy ◽

Phase I ◽

Cancer Recurrence ◽

Invasive Bladder Cancer ◽

Muscle Invasive ◽

Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapy

OncoImmunology ◽

10.1080/2162402x.2020.1748981 ◽

2020 ◽

Vol 9 (1) ◽

pp. 1748981 ◽

Cited By ~ 3

Author(s):

Cyrill A. Rentsch ◽

Piet Bosshard ◽

Grégoire Mayor ◽

Malte Rieken ◽

Heike Püschel ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Phase I ◽

Intravesical Instillation ◽

Invasive Bladder Cancer ◽

Open Label ◽

Bcg Therapy ◽

Muscle Invasive

A Study of Stimulator of Interferon Genes (STING) Agonist E7766 in Non-muscle Invasive Bladder Cancer (NMIBC) Including Participants Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy, INPUT-102

Case Medical Research ◽

10.31525/ct1-nct04109092 ◽

2019 ◽

Author(s):

Keyword(s):

Bladder Cancer ◽

Invasive Bladder Cancer ◽

Bcg Therapy ◽

Muscle Invasive

1786 A PROSPECTIVE COMPARATIVE STUDY OF INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) THERAPY WITH THE TOKYO OR CONNAUGHT STRAINS FOR NON-MUSCLE INVASIVE BLADDER CANCER

10.1016/j.juro.2013.02.2876 ◽

2013 ◽

Vol 189 (4S) ◽

Author(s):

Atsushi Sengiku ◽

Masaaki Ito ◽

Yu Miyazaki ◽

Harutake Sawazaki ◽

Takeshi Takahashi ◽

...

Keyword(s):

Bladder Cancer ◽

Comparative Study ◽

Invasive Bladder Cancer ◽

Bcg Therapy ◽

Prospective Comparative Study ◽

Muscle Invasive

Lifestyle and Non-muscle Invasive Bladder Cancer Recurrence, Progression, and Mortality: Available Research and Future Directions

Bladder Cancer ◽

10.3233/blc-190249 ◽

2020 ◽

Vol 6 (1) ◽

pp. 9-23

Author(s):

Kyle B. Zuniga ◽

Rebecca E. Graff ◽

David B. Feiger ◽

Maxwell V. Meng ◽

Sima P. Porten ◽

...

Keyword(s):

Bladder Cancer ◽

Cancer Recurrence ◽

Invasive Bladder Cancer ◽

Future Directions ◽

Muscle Invasive ◽

MP63-04 QUANTITATIVE NUCLEAR FEATURES OF HEMATOXYLIN-EOSIN SPECIMENS FROM INITIAL TRANSURETHRAL RESECTION FOR PREDICTING NON-MUSCLE INVASIVE BLADDER CANCER RECURRENCE

10.1097/01.ju.0000556847.87489.0a ◽

2019 ◽

Vol 201 (Supplement 4) ◽

Author(s):

Naoto Tokuyama* ◽

Akira Saito ◽

Yosuke Hirasawa ◽

Takeshi Hashimoto ◽

Naoya Satake ◽

...

Keyword(s):

Bladder Cancer ◽

Transurethral Resection ◽

Cancer Recurrence ◽

Invasive Bladder Cancer ◽

Muscle Invasive ◽

Bladder Cancer Recurrence ◽

Hematoxylin Eosin ◽

Nuclear Features

MP72-17 OSMOTIC CYTOLYTIC EFFECTS OF WATER ON CELL COUNTS – IMPLICATIONS FOR CLINICAL USE OF WATER IRRIGATION TO REDUCE NON-MUSCLE INVASIVE BLADDER CANCER RECURRENCE

10.1097/ju.0000000000000952.017 ◽

2020 ◽

Vol 203 ◽

pp. e1081

Author(s):

Ruchira Nandurkar* ◽

Mo Li ◽

Pavel Sluka ◽

Hady Wardan ◽

Ian Davis ◽

...

Keyword(s):

Bladder Cancer ◽

Cancer Recurrence ◽

Invasive Bladder Cancer ◽

Clinical Use ◽

Cell Counts ◽

Muscle Invasive ◽

PD60-04 SURVIVAL ANALYSIS AND PREDICTORS OF NON-MUSCLE INVASIVE BLADDER CANCER RECURRENCE IN CLINICAL COMPLETE-RESPONDERS AFTER NEOADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER

10.1097/ju.0000000000000977.04 ◽

2020 ◽

Vol 203 ◽

pp. e1274

Author(s):

Helena Vila-Reyes* ◽

Kevin Lee ◽

G.Joel Decastro ◽

Gen Li ◽

Christopher R. Haas ◽

...

Keyword(s):

Bladder Cancer ◽

Survival Analysis ◽

Neoadjuvant Chemotherapy ◽

Cancer Recurrence ◽

Invasive Bladder Cancer ◽

Muscle Invasive ◽

Evaluation of non-muscle-invasive bladder cancer recurrence using a mRNA-based urine test (Xpert® Bladder Cancer Monitor) and cytology

European Urology Supplements ◽

10.1016/s1569-9056(19)30687-6 ◽

2019 ◽

Vol 18 (1) ◽

pp. e945

Author(s):

G. Cancel-Tassin ◽

C. Ciofu ◽

J. Varinot ◽

M. Audouin ◽

V. Ondet ◽

...

Keyword(s):

Bladder Cancer ◽

Cancer Recurrence ◽

Invasive Bladder Cancer ◽

Urine Test ◽

Muscle Invasive ◽

URINE-BASED DETECTION OF NON-MUSCLE INVASIVE BLADDER CANCER RECURRENCE

Case Medical Research ◽

10.31525/ct1-nct03962933 ◽

2019 ◽

Author(s):

Keyword(s):

Bladder Cancer ◽

Cancer Recurrence ◽

Invasive Bladder Cancer ◽

Muscle Invasive ◽